US 11701341
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
granted A61KA61K31/415A61K9/0053
Quick answer
US patent 11701341 (Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease) held by MEREO BIOPHARMA 1 LIMITED expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MEREO BIOPHARMA 1 LIMITED
- Grant date
- Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/415, A61K9/0053, A61P, A61P11/00